Colfosceril palmitate
Jump to navigation
Jump to search
![]() | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Trade names | Exosurf |
| Other names | [2-({[2,3-bis(hexadecanoyloxy)propyl] phosphonato}oxy)ethyl]trimethylazanium |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C40H80NO8P |
| Molar mass | 734.039 g/mol |
| |
| Template:Xmark | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Colfosceril palmitate (trade name Exosurf) is a drug used as a pulmonary surfactant.It is a drug that is used in surfactant deficient conditions such as IRDS in newborns.
See also
References
Categories:
- Articles with short description
- Template:drugs.com link with non-standard subpage
- Articles with changed EBI identifier
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Organophosphates
- Drug
